{
    "title": "Novartis lifts 2023 earnings forecast for third time",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12664777/Novartis-lifts-2023-earnings-forecast-time.html",
    "date": "2023-10-24",
    "keywords": [
        "novartis",
        "drug",
        "sandoz",
        "group",
        "burger",
        "cost",
        "business",
        "core",
        "ms",
        "analyst",
        "consensus",
        "programme",
        "tuesday",
        "forecast",
        "time",
        "higherthanforecast",
        "sclerosis",
        "drugmaker",
        "statement",
        "income",
        "percentage",
        "mid",
        "doubledigit",
        "kesimpta",
        "treatment",
        "europe",
        "roche",
        "hospital",
        "infusion",
        "ceo",
        "vas",
        "narasimhan",
        "push",
        "spinoff",
        "reliance",
        "innovation",
        "investor",
        "pressure",
        "development",
        "win",
        "year",
        "breast",
        "cancer",
        "kisqali",
        "wider",
        "patient",
        "study",
        "efficiency",
        "job",
        "inflation",
        "outlook",
        "officer",
        "harry",
        "restructuring",
        "track",
        "standpoint",
        "kirsch",
        "call",
        "thirdquarter",
        "company",
        "operating",
        "profit",
        "estimate",
        "performance",
        "psoriasis",
        "cosentyx",
        "product",
        "entresto",
        "line",
        "market",
        "view",
        "heart",
        "failure",
        "battle",
        "end",
        "patent",
        "protection",
        "addition",
        "government",
        "medicare",
        "drugprice",
        "negotiation",
        "miranda",
        "murray",
        "fahmy"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}